| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Language Development Disorders | 16 | 2022 | 167 | 6.690 |
Why?
|
| Juvenile Delinquency | 14 | 2023 | 28 | 6.270 |
Why?
|
| Reading | 20 | 2021 | 81 | 4.940 |
Why?
|
| Dyslexia | 13 | 2021 | 24 | 4.790 |
Why?
|
| Child Development | 8 | 2020 | 255 | 4.160 |
Why?
|
| Language Development | 9 | 2021 | 30 | 3.350 |
Why?
|
| Epigenesis, Genetic | 11 | 2024 | 1399 | 2.700 |
Why?
|
| Intelligence | 9 | 2019 | 126 | 2.420 |
Why?
|
| Education, Special | 5 | 2019 | 8 | 2.300 |
Why?
|
| Cognition | 15 | 2023 | 968 | 2.260 |
Why?
|
| DNA Methylation | 10 | 2021 | 2669 | 2.150 |
Why?
|
| Child, Orphaned | 3 | 2020 | 18 | 2.050 |
Why?
|
| Child, Institutionalized | 5 | 2019 | 6 | 2.030 |
Why?
|
| Russia | 15 | 2021 | 54 | 1.920 |
Why?
|
| Child | 79 | 2022 | 29154 | 1.890 |
Why?
|
| Mother-Child Relations | 4 | 2018 | 81 | 1.830 |
Why?
|
| Evoked Potentials | 5 | 2023 | 190 | 1.690 |
Why?
|
| Institutionalization | 4 | 2023 | 13 | 1.680 |
Why?
|
| Autism Spectrum Disorder | 3 | 2022 | 363 | 1.660 |
Why?
|
| Cross-Cultural Comparison | 5 | 2016 | 87 | 1.630 |
Why?
|
| Adolescent Development | 3 | 2016 | 34 | 1.550 |
Why?
|
| Brain | 17 | 2021 | 4113 | 1.550 |
Why?
|
| Autistic Disorder | 7 | 2019 | 319 | 1.530 |
Why?
|
| Adolescent | 60 | 2023 | 31252 | 1.520 |
Why?
|
| Criminals | 2 | 2023 | 15 | 1.510 |
Why?
|
| Aptitude | 4 | 2021 | 11 | 1.500 |
Why?
|
| Violence | 3 | 2023 | 116 | 1.500 |
Why?
|
| Catechol O-Methyltransferase | 6 | 2020 | 34 | 1.490 |
Why?
|
| Mothers | 4 | 2024 | 410 | 1.440 |
Why?
|
| Language Tests | 9 | 2020 | 27 | 1.370 |
Why?
|
| Comprehension | 6 | 2018 | 120 | 1.370 |
Why?
|
| HIV Infections | 5 | 2022 | 2134 | 1.350 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 167 | 1.330 |
Why?
|
| Schools | 3 | 2019 | 233 | 1.310 |
Why?
|
| Prisoners | 3 | 2013 | 34 | 1.190 |
Why?
|
| Emotions | 2 | 2021 | 562 | 1.160 |
Why?
|
| Electroencephalography | 6 | 2023 | 898 | 1.160 |
Why?
|
| Parenting | 4 | 2021 | 345 | 1.150 |
Why?
|
| Maternal Behavior | 2 | 2018 | 62 | 1.150 |
Why?
|
| Child Behavior Disorders | 3 | 2020 | 68 | 1.150 |
Why?
|
| Recidivism | 3 | 2023 | 6 | 1.130 |
Why?
|
| Humans | 126 | 2024 | 261506 | 1.110 |
Why?
|
| Adoption | 2 | 2016 | 14 | 1.100 |
Why?
|
| Attention | 3 | 2020 | 281 | 1.090 |
Why?
|
| Language | 6 | 2021 | 309 | 1.020 |
Why?
|
| Male | 80 | 2023 | 123000 | 1.020 |
Why?
|
| Social Environment | 4 | 2012 | 176 | 1.010 |
Why?
|
| Psychological Tests | 2 | 2023 | 131 | 1.010 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 3 | 2018 | 34 | 0.990 |
Why?
|
| Psycholinguistics | 3 | 2020 | 11 | 0.980 |
Why?
|
| Child, Preschool | 26 | 2021 | 16273 | 0.980 |
Why?
|
| Child Behavior | 4 | 2020 | 243 | 0.960 |
Why?
|
| Child of Impaired Parents | 2 | 2020 | 17 | 0.960 |
Why?
|
| Polymorphism, Single Nucleotide | 18 | 2020 | 4549 | 0.960 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2020 | 5539 | 0.940 |
Why?
|
| Students | 3 | 2021 | 324 | 0.940 |
Why?
|
| Polymorphism, Genetic | 7 | 2020 | 1450 | 0.920 |
Why?
|
| Phonetics | 11 | 2021 | 46 | 0.910 |
Why?
|
| Pituitary-Adrenal System | 4 | 2024 | 97 | 0.910 |
Why?
|
| Child Abuse | 3 | 2018 | 193 | 0.900 |
Why?
|
| Cerebral Cortex | 5 | 2020 | 621 | 0.900 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 2024 | 127 | 0.890 |
Why?
|
| Teaching | 4 | 2019 | 243 | 0.880 |
Why?
|
| Reaction Time | 3 | 2020 | 234 | 0.880 |
Why?
|
| Housing | 2 | 2020 | 61 | 0.880 |
Why?
|
| Orphanages | 3 | 2020 | 6 | 0.880 |
Why?
|
| Learning | 5 | 2016 | 403 | 0.880 |
Why?
|
| Mental Health | 5 | 2021 | 415 | 0.880 |
Why?
|
| Conduct Disorder | 3 | 2015 | 26 | 0.870 |
Why?
|
| Models, Psychological | 3 | 2012 | 170 | 0.860 |
Why?
|
| Academic Performance | 1 | 2022 | 14 | 0.850 |
Why?
|
| Deafness | 1 | 2022 | 82 | 0.850 |
Why?
|
| Endophenotypes | 2 | 2012 | 18 | 0.830 |
Why?
|
| Adaptation, Psychological | 2 | 2019 | 764 | 0.830 |
Why?
|
| Female | 72 | 2024 | 141928 | 0.830 |
Why?
|
| Neuropsychological Tests | 7 | 2017 | 1178 | 0.820 |
Why?
|
| Knowledge | 1 | 2021 | 52 | 0.800 |
Why?
|
| Multilingualism | 1 | 2021 | 31 | 0.790 |
Why?
|
| Genetic Markers | 4 | 2020 | 974 | 0.790 |
Why?
|
| Writing | 2 | 2016 | 104 | 0.780 |
Why?
|
| Mental Disorders | 5 | 2018 | 862 | 0.780 |
Why?
|
| Facial Expression | 1 | 2021 | 49 | 0.780 |
Why?
|
| Genotype | 14 | 2020 | 4109 | 0.770 |
Why?
|
| Cytochrome P-450 CYP2B6 | 1 | 2020 | 22 | 0.760 |
Why?
|
| Social Support | 2 | 2020 | 560 | 0.760 |
Why?
|
| Connecticut | 5 | 2023 | 33 | 0.750 |
Why?
|
| Benzoxazines | 1 | 2020 | 27 | 0.750 |
Why?
|
| Alkynes | 1 | 2020 | 29 | 0.750 |
Why?
|
| Problem Solving | 2 | 2020 | 85 | 0.750 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 4 | 2012 | 274 | 0.740 |
Why?
|
| Art Therapy | 1 | 2020 | 1 | 0.740 |
Why?
|
| Child, Gifted | 1 | 2020 | 2 | 0.740 |
Why?
|
| Genomics | 4 | 2022 | 2738 | 0.740 |
Why?
|
| Child Welfare | 1 | 2020 | 66 | 0.730 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2020 | 61 | 0.730 |
Why?
|
| Cyclopropanes | 1 | 2020 | 88 | 0.730 |
Why?
|
| Psychosocial Deprivation | 1 | 2019 | 8 | 0.730 |
Why?
|
| Longitudinal Studies | 10 | 2022 | 1945 | 0.720 |
Why?
|
| Adolescent Health | 1 | 2020 | 15 | 0.720 |
Why?
|
| Disabled Children | 1 | 2020 | 26 | 0.710 |
Why?
|
| Criminal Behavior | 1 | 2019 | 3 | 0.710 |
Why?
|
| Zambia | 6 | 2022 | 26 | 0.700 |
Why?
|
| Psychometrics | 4 | 2019 | 937 | 0.700 |
Why?
|
| Community Health Services | 1 | 2020 | 126 | 0.690 |
Why?
|
| Child Health | 1 | 2020 | 54 | 0.690 |
Why?
|
| Depression | 3 | 2018 | 1715 | 0.680 |
Why?
|
| Pharmacogenetics | 2 | 2020 | 260 | 0.680 |
Why?
|
| Achievement | 3 | 2014 | 41 | 0.680 |
Why?
|
| Adult Survivors of Child Adverse Events | 1 | 2019 | 20 | 0.680 |
Why?
|
| Academic Success | 1 | 2019 | 22 | 0.680 |
Why?
|
| Substance-Related Disorders | 2 | 2021 | 524 | 0.670 |
Why?
|
| Hydrocortisone | 3 | 2021 | 388 | 0.670 |
Why?
|
| White Matter | 1 | 2021 | 195 | 0.660 |
Why?
|
| Down Syndrome | 1 | 2021 | 226 | 0.660 |
Why?
|
| Social Adjustment | 2 | 2016 | 114 | 0.650 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 2018 | 81 | 0.640 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 117 | 0.640 |
Why?
|
| Frontal Lobe | 3 | 2016 | 187 | 0.640 |
Why?
|
| Genetic Linkage | 2 | 2011 | 512 | 0.630 |
Why?
|
| Rural Population | 3 | 2015 | 281 | 0.630 |
Why?
|
| Haplotypes | 10 | 2020 | 856 | 0.610 |
Why?
|
| Neuropsychology | 1 | 2017 | 33 | 0.610 |
Why?
|
| Adolescent Behavior | 2 | 2017 | 230 | 0.600 |
Why?
|
| Young Adult | 20 | 2021 | 21445 | 0.600 |
Why?
|
| Research | 1 | 2020 | 415 | 0.590 |
Why?
|
| Anti-HIV Agents | 1 | 2020 | 350 | 0.590 |
Why?
|
| Infant | 11 | 2024 | 13310 | 0.570 |
Why?
|
| Emotional Adjustment | 1 | 2016 | 7 | 0.560 |
Why?
|
| Language Disorders | 2 | 2016 | 26 | 0.560 |
Why?
|
| Social Perception | 1 | 2016 | 76 | 0.560 |
Why?
|
| Carrier Proteins | 3 | 2020 | 2022 | 0.550 |
Why?
|
| Creativity | 1 | 2016 | 13 | 0.550 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 1491 | 0.550 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 338 | 0.540 |
Why?
|
| Vocabulary | 4 | 2020 | 23 | 0.540 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2015 | 96 | 0.530 |
Why?
|
| Child, Abandoned | 1 | 2015 | 2 | 0.520 |
Why?
|
| Foster Home Care | 1 | 2015 | 18 | 0.510 |
Why?
|
| Child Care | 1 | 2015 | 15 | 0.510 |
Why?
|
| Genome-Wide Association Study | 5 | 2020 | 2265 | 0.510 |
Why?
|
| Global Health | 1 | 2020 | 657 | 0.500 |
Why?
|
| Prisons | 1 | 2014 | 15 | 0.500 |
Why?
|
| Educational Status | 4 | 2020 | 397 | 0.490 |
Why?
|
| Gene-Environment Interaction | 2 | 2013 | 166 | 0.490 |
Why?
|
| Marijuana Smoking | 1 | 2014 | 39 | 0.480 |
Why?
|
| Developing Countries | 3 | 2020 | 315 | 0.480 |
Why?
|
| Genetic Association Studies | 5 | 2017 | 1084 | 0.480 |
Why?
|
| Models, Educational | 2 | 2011 | 95 | 0.470 |
Why?
|
| Crime | 4 | 2019 | 31 | 0.460 |
Why?
|
| Surveys and Questionnaires | 6 | 2020 | 5687 | 0.450 |
Why?
|
| Cannabis | 1 | 2014 | 65 | 0.450 |
Why?
|
| Models, Genetic | 5 | 2013 | 1113 | 0.440 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2020 | 176 | 0.440 |
Why?
|
| Psychotherapy | 1 | 2015 | 247 | 0.440 |
Why?
|
| Verbal Behavior | 1 | 2012 | 62 | 0.430 |
Why?
|
| Personality Assessment | 2 | 2010 | 105 | 0.420 |
Why?
|
| Maternal Deprivation | 1 | 2011 | 15 | 0.420 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 2291 | 0.410 |
Why?
|
| Twins | 1 | 2012 | 70 | 0.410 |
Why?
|
| Stress, Psychological | 3 | 2021 | 1000 | 0.410 |
Why?
|
| Semantics | 3 | 2023 | 58 | 0.410 |
Why?
|
| Speech Perception | 5 | 2013 | 66 | 0.410 |
Why?
|
| Mathematics | 1 | 2011 | 136 | 0.400 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 3343 | 0.400 |
Why?
|
| Character | 1 | 2010 | 5 | 0.390 |
Why?
|
| Consensus | 1 | 2015 | 978 | 0.390 |
Why?
|
| Anger | 2 | 2021 | 21 | 0.390 |
Why?
|
| Educational Measurement | 1 | 2013 | 362 | 0.380 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2011 | 126 | 0.380 |
Why?
|
| Stroop Test | 2 | 2020 | 6 | 0.380 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 442 | 0.380 |
Why?
|
| Child Language | 4 | 2015 | 15 | 0.380 |
Why?
|
| Developmental Disabilities | 2 | 2021 | 674 | 0.370 |
Why?
|
| Publishing | 1 | 2012 | 220 | 0.370 |
Why?
|
| Phenotype | 8 | 2020 | 6295 | 0.370 |
Why?
|
| Decision Making | 3 | 2013 | 1287 | 0.370 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2014 | 269 | 0.370 |
Why?
|
| History, 20th Century | 3 | 2019 | 574 | 0.360 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2012 | 1498 | 0.360 |
Why?
|
| Checklist | 1 | 2010 | 122 | 0.360 |
Why?
|
| Individuality | 3 | 2014 | 58 | 0.350 |
Why?
|
| Remedial Teaching | 1 | 2008 | 5 | 0.340 |
Why?
|
| Aptitude Tests | 1 | 2008 | 9 | 0.340 |
Why?
|
| Auditory Perception | 2 | 2022 | 35 | 0.340 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 4053 | 0.340 |
Why?
|
| Risk Factors | 10 | 2018 | 17523 | 0.330 |
Why?
|
| Family | 1 | 2012 | 736 | 0.330 |
Why?
|
| Cognition Disorders | 2 | 2016 | 786 | 0.330 |
Why?
|
| Dopamine | 1 | 2010 | 312 | 0.320 |
Why?
|
| Gene Expression Profiling | 5 | 2016 | 5159 | 0.320 |
Why?
|
| Adult | 20 | 2023 | 77950 | 0.320 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 40 | 0.320 |
Why?
|
| Aggression | 1 | 2010 | 252 | 0.320 |
Why?
|
| Neuroimaging | 2 | 2021 | 403 | 0.310 |
Why?
|
| Genetic Testing | 2 | 2021 | 1589 | 0.310 |
Why?
|
| Lymphocytes | 1 | 2012 | 1234 | 0.310 |
Why?
|
| Speech Disorders | 1 | 2007 | 91 | 0.300 |
Why?
|
| Gene Expression | 3 | 2012 | 3570 | 0.300 |
Why?
|
| Genetic Variation | 3 | 2018 | 2086 | 0.300 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 4314 | 0.290 |
Why?
|
| Neuronal Plasticity | 2 | 2021 | 304 | 0.290 |
Why?
|
| Body Mass Index | 1 | 2014 | 2203 | 0.290 |
Why?
|
| History, 21st Century | 2 | 2019 | 441 | 0.280 |
Why?
|
| Translocation, Genetic | 1 | 2011 | 1245 | 0.280 |
Why?
|
| Parietal Lobe | 3 | 2021 | 66 | 0.260 |
Why?
|
| Gene Frequency | 8 | 2018 | 1163 | 0.260 |
Why?
|
| Saliva | 3 | 2018 | 231 | 0.260 |
Why?
|
| Microcephaly | 2 | 2021 | 325 | 0.250 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 3869 | 0.250 |
Why?
|
| United States | 6 | 2020 | 15433 | 0.240 |
Why?
|
| Antisocial Personality Disorder | 2 | 2015 | 62 | 0.240 |
Why?
|
| Pattern Recognition, Visual | 1 | 2003 | 35 | 0.240 |
Why?
|
| Brain Mapping | 5 | 2021 | 644 | 0.240 |
Why?
|
| Depressive Disorder | 1 | 2008 | 557 | 0.230 |
Why?
|
| Dopamine beta-Hydroxylase | 2 | 2015 | 38 | 0.230 |
Why?
|
| Genome, Human | 1 | 2011 | 1869 | 0.230 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2022 | 31 | 0.220 |
Why?
|
| Megalencephaly | 2 | 2021 | 56 | 0.220 |
Why?
|
| Poverty | 2 | 2018 | 471 | 0.220 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2021 | 341 | 0.210 |
Why?
|
| Mammals | 1 | 2024 | 361 | 0.210 |
Why?
|
| Mental Recall | 2 | 2015 | 171 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2003 | 179 | 0.210 |
Why?
|
| Statistics as Topic | 3 | 2010 | 445 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2021 | 7702 | 0.200 |
Why?
|
| Awareness | 4 | 2013 | 126 | 0.200 |
Why?
|
| Principal Component Analysis | 2 | 2019 | 218 | 0.200 |
Why?
|
| Neurites | 1 | 2021 | 63 | 0.200 |
Why?
|
| Linguistics | 2 | 2019 | 25 | 0.200 |
Why?
|
| Cohort Studies | 3 | 2022 | 9244 | 0.200 |
Why?
|
| Health Risk Behaviors | 1 | 2020 | 6 | 0.200 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 6009 | 0.190 |
Why?
|
| Speech | 3 | 2012 | 133 | 0.190 |
Why?
|
| Abnormalities, Multiple | 2 | 2021 | 998 | 0.190 |
Why?
|
| Public Policy | 1 | 2020 | 60 | 0.190 |
Why?
|
| Cell Count | 1 | 2021 | 508 | 0.190 |
Why?
|
| Mutation | 1 | 2020 | 15179 | 0.180 |
Why?
|
| Anxiety | 2 | 2018 | 1179 | 0.180 |
Why?
|
| Art | 1 | 2020 | 4 | 0.180 |
Why?
|
| Residential Facilities | 1 | 2020 | 5 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2011 | 231 | 0.180 |
Why?
|
| Socialization | 1 | 2019 | 16 | 0.180 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 543 | 0.180 |
Why?
|
| Developed Countries | 1 | 2020 | 42 | 0.180 |
Why?
|
| Receptors, Immunologic | 1 | 2021 | 309 | 0.180 |
Why?
|
| Saudi Arabia | 1 | 2019 | 39 | 0.180 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2015 | 901 | 0.180 |
Why?
|
| DNA Copy Number Variations | 3 | 2022 | 1516 | 0.170 |
Why?
|
| Algorithms | 1 | 2011 | 3890 | 0.170 |
Why?
|
| Regression Analysis | 2 | 2017 | 1546 | 0.170 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 233 | 0.170 |
Why?
|
| Social Behavior | 2 | 2019 | 306 | 0.170 |
Why?
|
| Prevalence | 2 | 2019 | 3260 | 0.170 |
Why?
|
| Income | 1 | 2020 | 222 | 0.170 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 534 | 0.160 |
Why?
|
| Maternal-Child Nursing | 1 | 2018 | 1 | 0.160 |
Why?
|
| Health Status | 2 | 2015 | 590 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2020 | 362 | 0.160 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 192 | 0.160 |
Why?
|
| House Calls | 1 | 2018 | 39 | 0.150 |
Why?
|
| Perinatal Care | 1 | 2018 | 63 | 0.150 |
Why?
|
| Sex Education | 1 | 2017 | 26 | 0.150 |
Why?
|
| Verbal Learning | 2 | 2011 | 84 | 0.150 |
Why?
|
| Memory, Short-Term | 2 | 2018 | 160 | 0.140 |
Why?
|
| Urban Population | 1 | 2018 | 269 | 0.140 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 552 | 0.140 |
Why?
|
| Genetics, Population | 1 | 2017 | 242 | 0.140 |
Why?
|
| Choline Kinase | 1 | 2015 | 2 | 0.140 |
Why?
|
| Memory | 2 | 2016 | 429 | 0.140 |
Why?
|
| Age Factors | 2 | 2016 | 5377 | 0.140 |
Why?
|
| Nerve Net | 1 | 2019 | 257 | 0.140 |
Why?
|
| Siblings | 1 | 2017 | 285 | 0.140 |
Why?
|
| Telencephalon | 1 | 2015 | 11 | 0.140 |
Why?
|
| Microsatellite Repeats | 2 | 2011 | 575 | 0.130 |
Why?
|
| Hippocampus | 3 | 2017 | 915 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 3 | 2016 | 2483 | 0.130 |
Why?
|
| Aging | 3 | 2012 | 1582 | 0.130 |
Why?
|
| Animals | 10 | 2024 | 59536 | 0.130 |
Why?
|
| Rats | 1 | 2024 | 6086 | 0.130 |
Why?
|
| Maternal-Fetal Relations | 1 | 2014 | 14 | 0.130 |
Why?
|
| Universities | 1 | 2016 | 160 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 677 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 264 | 0.120 |
Why?
|
| Sex Factors | 2 | 2015 | 2139 | 0.120 |
Why?
|
| Self Report | 1 | 2018 | 756 | 0.120 |
Why?
|
| Pedigree | 3 | 2021 | 1890 | 0.120 |
Why?
|
| Temporal Lobe | 2 | 2012 | 192 | 0.120 |
Why?
|
| Visual Perception | 2 | 2012 | 154 | 0.120 |
Why?
|
| Choline | 1 | 2014 | 76 | 0.120 |
Why?
|
| Codon, Nonsense | 1 | 2014 | 164 | 0.120 |
Why?
|
| Mental Processes | 2 | 2010 | 53 | 0.120 |
Why?
|
| Body Height | 1 | 2014 | 231 | 0.110 |
Why?
|
| Health Status Indicators | 1 | 2014 | 224 | 0.110 |
Why?
|
| USSR | 1 | 2012 | 6 | 0.110 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1032 | 0.110 |
Why?
|
| Neurogenesis | 1 | 2015 | 238 | 0.110 |
Why?
|
| Sequence Analysis | 1 | 2012 | 73 | 0.110 |
Why?
|
| Autopsy | 1 | 2012 | 173 | 0.110 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 118 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 14889 | 0.110 |
Why?
|
| Glutamic Acid | 1 | 2014 | 309 | 0.100 |
Why?
|
| Semaphorins | 1 | 2011 | 38 | 0.100 |
Why?
|
| DNA Mutational Analysis | 2 | 2008 | 2283 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2014 | 624 | 0.100 |
Why?
|
| Homozygote | 1 | 2014 | 717 | 0.100 |
Why?
|
| Chromosome Breakpoints | 1 | 2011 | 104 | 0.100 |
Why?
|
| Neocortex | 1 | 2012 | 98 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2011 | 135 | 0.100 |
Why?
|
| Stem Cell Research | 1 | 2011 | 6 | 0.100 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 356 | 0.100 |
Why?
|
| Alleles | 4 | 2018 | 2437 | 0.100 |
Why?
|
| Cattle | 1 | 2012 | 783 | 0.100 |
Why?
|
| Middle Aged | 8 | 2018 | 86204 | 0.100 |
Why?
|
| Neuropsychiatry | 1 | 2011 | 13 | 0.100 |
Why?
|
| Lod Score | 1 | 2011 | 157 | 0.100 |
Why?
|
| Chromosome Duplication | 1 | 2011 | 157 | 0.100 |
Why?
|
| Prostatectomy | 1 | 2015 | 962 | 0.100 |
Why?
|
| Occipital Lobe | 1 | 2011 | 48 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2011 | 64 | 0.100 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2015 | 413 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 778 | 0.090 |
Why?
|
| Monoamine Oxidase | 1 | 2010 | 14 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2011 | 159 | 0.090 |
Why?
|
| Diseases in Twins | 1 | 2011 | 99 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2023 | 6869 | 0.090 |
Why?
|
| Exome | 1 | 2016 | 1239 | 0.090 |
Why?
|
| Cell Line | 3 | 2014 | 5114 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 244 | 0.090 |
Why?
|
| Gambia | 1 | 2009 | 29 | 0.090 |
Why?
|
| Poisson Distribution | 1 | 2010 | 91 | 0.090 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 878 | 0.090 |
Why?
|
| Bias | 1 | 2010 | 205 | 0.090 |
Why?
|
| Body Weight | 1 | 2014 | 1293 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 2508 | 0.090 |
Why?
|
| CpG Islands | 1 | 2011 | 633 | 0.090 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2009 | 10 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2021 | 12873 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1697 | 0.090 |
Why?
|
| Chromosome Disorders | 1 | 2011 | 417 | 0.090 |
Why?
|
| Disease Progression | 1 | 2020 | 6682 | 0.080 |
Why?
|
| Observer Variation | 1 | 2010 | 671 | 0.080 |
Why?
|
| Netherlands | 1 | 2008 | 83 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2011 | 641 | 0.080 |
Why?
|
| Base Sequence | 2 | 2013 | 4917 | 0.080 |
Why?
|
| Neurons | 4 | 2016 | 2287 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2014 | 6100 | 0.080 |
Why?
|
| Parents | 1 | 2015 | 998 | 0.080 |
Why?
|
| Selection, Genetic | 2 | 2011 | 189 | 0.080 |
Why?
|
| Mutagenesis, Insertional | 1 | 2009 | 218 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 1439 | 0.080 |
Why?
|
| Mice | 4 | 2024 | 34495 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2011 | 403 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 3101 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 1 | 2008 | 257 | 0.070 |
Why?
|
| Underachievement | 1 | 2006 | 1 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2008 | 259 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 3203 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 2232 | 0.070 |
Why?
|
| Helminthiasis | 1 | 2007 | 67 | 0.070 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2005 | 33 | 0.070 |
Why?
|
| Vitamins | 1 | 2007 | 157 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 1225 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2330 | 0.070 |
Why?
|
| Reference Values | 1 | 2007 | 1099 | 0.060 |
Why?
|
| Time Factors | 2 | 2016 | 12926 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2013 | 2803 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 3154 | 0.060 |
Why?
|
| Genetic Drift | 1 | 2004 | 30 | 0.060 |
Why?
|
| Comorbidity | 1 | 2011 | 2352 | 0.060 |
Why?
|
| Transcriptome | 1 | 2012 | 1859 | 0.060 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2004 | 103 | 0.060 |
Why?
|
| Alcoholism | 1 | 2005 | 285 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2008 | 2316 | 0.050 |
Why?
|
| Logistic Models | 1 | 2010 | 3441 | 0.050 |
Why?
|
| Linkage Disequilibrium | 3 | 2011 | 460 | 0.050 |
Why?
|
| Family Health | 1 | 2003 | 325 | 0.050 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 613 | 0.050 |
Why?
|
| Photic Stimulation | 2 | 2012 | 259 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 4298 | 0.050 |
Why?
|
| Failure to Thrive | 1 | 2021 | 91 | 0.050 |
Why?
|
| Seizures | 2 | 2021 | 989 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 834 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2021 | 327 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 1471 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2021 | 380 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 5767 | 0.040 |
Why?
|
| DNA | 2 | 2005 | 2693 | 0.040 |
Why?
|
| Nurse-Patient Relations | 1 | 2018 | 23 | 0.040 |
Why?
|
| Pregnancy | 3 | 2018 | 7573 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 597 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2015 | 11965 | 0.040 |
Why?
|
| Aged | 5 | 2016 | 70117 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 148 | 0.040 |
Why?
|
| Canada | 1 | 2018 | 429 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 10331 | 0.040 |
Why?
|
| Chromosome Deletion | 1 | 2021 | 1005 | 0.030 |
Why?
|
| War Exposure | 1 | 2015 | 8 | 0.030 |
Why?
|
| Exposure to Violence | 1 | 2015 | 9 | 0.030 |
Why?
|
| Psychological Trauma | 1 | 2015 | 14 | 0.030 |
Why?
|
| Intimate Partner Violence | 1 | 2015 | 26 | 0.030 |
Why?
|
| Organ Size | 1 | 2017 | 690 | 0.030 |
Why?
|
| Pregnancy in Adolescence | 1 | 2015 | 58 | 0.030 |
Why?
|
| Neurocognitive Disorders | 1 | 2015 | 69 | 0.030 |
Why?
|
| Social Skills | 1 | 2014 | 21 | 0.030 |
Why?
|
| Speech Discrimination Tests | 1 | 2014 | 1 | 0.030 |
Why?
|
| Heterozygote | 1 | 2017 | 1020 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 2014 | 126 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 905 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 203 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2013 | 166 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 4892 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 14289 | 0.030 |
Why?
|
| Organoids | 1 | 2015 | 287 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2015 | 37905 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2018 | 666 | 0.030 |
Why?
|
| Eye Color | 1 | 2011 | 7 | 0.030 |
Why?
|
| Skin Pigmentation | 1 | 2011 | 47 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 2012 | 71 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 1869 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2015 | 2307 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 1742 | 0.020 |
Why?
|
| Visual Cortex | 1 | 2012 | 136 | 0.020 |
Why?
|
| Prognosis | 1 | 2008 | 21713 | 0.020 |
Why?
|
| Genomic Structural Variation | 1 | 2011 | 77 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2012 | 140 | 0.020 |
Why?
|
| Europe | 1 | 2011 | 649 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 123 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2015 | 787 | 0.020 |
Why?
|
| Genetics, Behavioral | 1 | 2008 | 9 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 651 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2009 | 51 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2009 | 136 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2009 | 354 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2010 | 298 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 1879 | 0.020 |
Why?
|
| Cues | 1 | 2009 | 192 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3821 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 4988 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 1399 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2009 | 467 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 3254 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 854 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6207 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2009 | 369 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 2594 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 1070 | 0.020 |
Why?
|
| Aldehyde Dehydrogenase, Mitochondrial | 1 | 2004 | 3 | 0.020 |
Why?
|
| Hominidae | 1 | 2004 | 37 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2004 | 201 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 2927 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 6089 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 13658 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8873 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 6150 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8223 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 7222 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 29902 | 0.010 |
Why?
|